首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1696269

日本微生物培養市場 - 2025 至 2033 年

Japan Microbiology Culture Market - 2025-2033

出版日期: 2025年03月25日 | 出版商:

DataM Intelligence | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年日本微生物培養市場規模達到 10.5718 億美元，預計到 2033 年將達到 21.8582 億美元，2025-2033 年預測期內的複合年成長率為 8.5%。

微生物培養是一種培養微生物以確定其身份、樣本中的豐度或兩者的方法。它是微生物學的主要診斷方法之一。培養微生物需要適當的物理環境，包括受控的 pH 值、大氣氣體、溫度和壓力。微生物培養基製備包括混合營養物質、緩衝劑、滲透平衡調節劑和選擇性抑制劑或指示劑，以產生支持微生物生長和分化的瓊脂或肉湯。該過程是微生物測試中監測腐敗和致病微生物的常規任務。

市場動態：

促進因素與約束因素

傳染病發生率上升

傳染病增加了對微生物培養技術的需求，因為準確的病原體鑑定、抗菌素抗藥性測試和疾病監測對於早期診斷、治療和疫情控制至關重要。

隨著日本傳染病數量的增加，對先進的診斷工具、研究和治療開發的需求也日益增加。隨著細菌、病毒和真菌感染的不斷增加，醫療保健提供者和研究機構越來越依賴微生物培養來準確識別病原體、確定抗生素抗藥性並制定有效的治療策略。

日本支原體肺炎病例正在大幅增加，患者數量達到近十年來同期的最高水準。肺炎是日本第五大死因。例如，日本國立傳染病研究所的資料顯示，截至 2024 年 10 月的一周，全國平均每家醫療機構報告病例 2.01 例，這是該數字首次超過每家醫療機構 2 例。傳染病數量的增加預計將增加對養殖設備、養殖補充劑和其他儀器的需求。因此，預計傳染病數量的增加將推動該國市場的成長。

污染和結果不一致的風險

預計污染風險和不一致的結果將影響微生物培養的準確性和可靠性，從而阻礙日本微生物培養市場的成長。培養基製備、儲存或處理過程中的污染會導致錯誤結果，從而損害診斷和研究結果的品質。不一致或不可靠的結果不僅會影響微生物檢測的效率，還會增加誤診的風險，造成嚴重的公共衛生後果。這可能導致治療延誤、抗生素使用不當以及對結果缺乏信心，最終引起醫療保健專業人員和研究人員的擔憂。

市場領導者和先驅者
- 新興先鋒和傑出參與者
- 擁有最大銷售品牌的成熟領導者
- 擁有成熟產品的市場領導者
CXO 觀點
最新進展與突破
案例研究/正在進行的研究
北美監管與報銷格局
波特五力分析
供應鏈分析
專利分析
SWOT 分析
未滿足的需求和差距
市場進入和擴張的推薦策略
情境分析：最佳情況、基本情況和最壞情況預測
定價分析和價格動態
關鍵意見領袖

第 5 章：微生物培養市場（依產品類型）

文化設備
- 生物反應器
  - 生物反應器設備
  - 測量儀器
  - PH 感測器
  - 溶氧感知器
  - 溫度感測器
  - 其他
  - 分析設備
  - 細胞計數器
  - 光譜儀
  - 其他
  - 滅菌設備
  - 孵化器
  - 其他
文化補編
測量儀器
- PH 感測器
- 溫度感測器
- 溶氧感知器
- 其他
文化儀器
- 培養皿
- 線圈與針
- 微量移液器
- 離心機
- 其他
分析設備
- 細胞計數器
- 光譜儀
- 其他

第 6 章：微生物培養市場（依培養類型）

真核培養
細菌培養

第 7 章：微生物培養市場（按一致性）

液體培養基
固體培養基
半固體培養基

第 8 章：微生物培養市場（按應用）

藥品
食品飲料業
水質檢測
化妝品

第9章：競爭格局與市場定位

競爭概況和主要市場參與者
市佔率分析與定位矩陣
策略夥伴關係、併購
產品組合和創新的關鍵發展
公司基準化分析

第10章：公司簡介

Merck KGaA

公司概況
產品組合
- 產品描述
- 產品關鍵績效指標 (KPI)
- 歷史和預測產品銷售量
- 產品銷售量
財務概覽
- 公司收入
- 地區收入佔有率
- 收入預測
關鍵進展
- 合併與收購
- 關鍵產品開發活動
- 監管部門批准等
SWOT 分析

Yokogawa Electric Corporation
SATAKE MultiMix Corporation
BEMARUBISHI CO., LTD.
ABLE Corporation & Biott Corporation
Eiken Chemical co. Lti.
BioMerieux SA
Thermo Fisher Scientific, Inc.
Sartorius AG
Kerry Group plc.

第 11 章：假設與研究方法

資料收集方法
數據三角測量
預測技術
數據驗證和確認

第 12 章：附錄

簡介目錄

Product Code: BT9378

The Japan microbiology culture market reached US$ 1,057.18 million in 2024 and is expected to reach US$ 2,185.82 million by 2033, growing at a CAGR of 8.5% during the forecast period 2025-2033.

A microbiology culture, or microbial culture, is a method of growing a microbial organism to determine its identity, its abundance in a sample, or both. It is one of the primary diagnostic methods in microbiology. Growing a microbial culture requires an appropriate physical environment with controlled pH, atmospheric gases, temperature, and pressure. Microbial culture media preparation involves mixing nutrients, buffering agents, osmotic balance regulators, and selective inhibitors or indicators to create agar or broth that supports microbial growth and differentiation. This process is a routine task in microbiological testing for monitoring spoilage and pathogenic microbes.

Market Dynamics: Drivers & Restraints

Rising Prevalence of Infectious Diseases

Infectious diseases increase the demand for microbiology culture technologies, as accurate pathogen identification, antimicrobial resistance testing, and disease surveillance become essential for early diagnosis, treatment, and outbreak control.

With the increasing number of infectious diseases in Japan there is an increasing need for advanced diagnostic tools, research, and treatment development. With the growing number of bacterial, viral, and fungal infections, healthcare providers and research institutions are relying more on microbiology cultures to accurately identify pathogens, determine antibiotic resistance, and develop effective treatment strategies.

Japan is experiencing a significant rise in mycoplasma pneumonia cases, with patient numbers reaching the highest levels for this time of year in the past decade. Pneumonia was the fifth leading cause of death in Japan. For instance, data from Japan's National Institute of Infectious Diseases showed that, for the week ending October 2024, an average of 2.01 cases per medical institution were reported nationwide, marking the first time this figure surpassed two cases per facility. This increase in the number of infectious diseases is expected to increase the demand for culture equipment, culture supplements, and other instruments. Thus, the increasing number of infectious diseases is expected to drive the country's market growth.

Risk of Contamination and Inconsistent Results

The risk of contamination and inconsistent results is expected to hinder the growth of the Japan microbiology culture market by affecting the accuracy and reliability of microbial cultures. Contamination during the preparation, storage, or handling of culture media can lead to false results, compromising the quality of diagnostics and research outcomes. Inconsistent or unreliable results not only impact the efficiency of microbiological testing but also increase the risk of misdiagnosis, which can have serious public health consequences. This can lead to delays in treatment, improper use of antibiotics, and a lack of confidence in the results, ultimately raising concerns among healthcare professionals and researchers.

Segment Analysis

The Japan microbiology culture Market is segmented based on the product type, culture type, consistency, and application.

Culture equipment in the product type segment is expected to dominate the microbiology culture market

Culture equipment in the product type segment is vital in the precise growth, isolation, and analysis of microorganisms. With the growing demand for advanced microbiological research, clinical diagnostics, and pharmaceutical development, the need for specialized culture equipment like incubators, autoclaves, and sterile handling instruments is becoming increasingly important.

Japan's advanced healthcare and biotechnology sectors require high-precision equipment to ensure the reliability of microbial culture processes. For various microbiology culturing and processing purposes, companies are introducing innovative microbiology culture solutions which is driving the segment's growth. For instance, in April 2023, Otsuka Techno Corporation, a subsidiary of Otsuka Pharmaceutical Factory, launched the OT-Algae, a resin-bag type microalgae culture device, as part of its environmentally friendly manufacturing efforts.

Competitive Landscape

The market players in the microbiology culture market are Merck KGaA, Yokogawa Electric Corporation, SATAKE MultiMix Corporation, B.E.MARUBISHI CO., LTD., ABLE Corporation & Biott Corporation, Eiken Chemical co. Lti., BioMerieux S.A., Thermo Fisher Scientific, Inc., Sartorius AG, and Kerry Group plc. among others.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming pharmaceutical advancements.
Type Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient Type delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Japan microbiology culture market report would provide approximately 42 tables, 33t figures, and 180 pages.

Target Audience 2024

Manufacturers: Pharmaceutical, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Market Introduction and Scope

1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope

2. Executive Insights and Key Takeaways

2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Product Type
2.4. Snippet by Culture Type
2.5. Snippet by Consistency
2.6. Snippet by Application

3. Dynamics

3.1. Impacting Factors
- 3.1.1. Drivers
  - 3.1.1.1. Rising Prevalence of Infectious Diseases
  - 3.1.1.2. Increasing R&D Investments in Microbiology and Life Sciences
- 3.1.2. Restraints
  - 3.1.2.1. Stringent Regulatory Framework for Culture Media Production
  - 3.1.2.2. Risk of Contamination and Inconsistent Results
- 3.1.3. Opportunity
  - 3.1.3.1. Potential for Innovative Culture Media for Fastidious Microorganisms
- 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

4.1. Market Leaders and Pioneers
- 4.1.1. Emerging Pioneers and Prominent Players
- 4.1.2. Established leaders with largest selling Brand
- 4.1.3. Market leaders with established Product
4.2. CXO Perspectives
4.3. Latest Developments and Breakthroughs
4.4. Case Studies/Ongoing Research
4.5. North America Regulatory and Reimbursement Landscape
4.6. Porter's Five Force Analysis
4.7. Supply Chain Analysis
4.8. Patent Analysis
4.9. SWOT Analysis
4.10. Unmet Needs and Gaps
4.11. Recommended Strategies for Market Entry and Expansion
4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
4.13. Pricing Analysis and Price Dynamics
4.14. Key Opinion Leaders

5. Microbiology Culture Market, By Product Type

5.1. Introduction
- 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 5.1.2. Market Attractiveness Index, By Product Type
5.2. Culture Equipment*
- 5.2.1. Introduction
- 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 5.2.3. Bioreactors
  - 5.2.3.1. Bioreactor Devices
  - 5.2.3.2. Measuring Instruments
  - 5.2.3.2.1. PH Sensors
  - 5.2.3.2.2. Dissolved Oxygen Sensors
  - 5.2.3.2.3. Temperature Sensors
  - 5.2.3.2.4. Others
  - 5.2.3.3. Analytical Devices
  - 5.2.3.3.1. Cell Counters
  - 5.2.3.3.2. Spectrometers
  - 5.2.3.3.3. Others
  - 5.2.3.4. Sterilization Equipment
  - 5.2.3.5. Incubators
  - 5.2.3.6. Others
5.3. Culture Supplements
5.4. Measuring Instruments
- 5.4.1. PH Sensors
- 5.4.2. Temperature Sensors
- 5.4.3. Dissolved Oxygen Sensors
- 5.4.4. Others
5.5. Culture Instruments
- 5.5.1. Petri Dishes
- 5.5.2. Loops & Needles
- 5.5.3. Micropipettes
- 5.5.4. Centrifuge
- 5.5.5. Others
5.6. Analytical Devices
- 5.6.1. Cell Counters
- 5.6.2. Spectrometers
- 5.6.3. Others

6. Microbiology Culture Market, By Culture Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Culture Type
- 6.1.2. Market Attractiveness Index, By Culture Type
6.2. Eukaryotic Culture*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Bacterial Culture

7. Microbiology Culture Market, By Consistency

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Consistency
- 7.1.2. Market Attractiveness Index, By Consistency
7.2. Liquid Media*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Solid Culture Media
7.4. Semi-solid Media

8. Microbiology Culture Market, By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Pharmaceuticals*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Food & Beverage Industry
8.4. Water Testing
8.5. Cosmetics

9. Competitive Landscape and Market Positioning

9.1. Competitive Overview and Key Market Players
9.2. Market Share Analysis and Positioning Matrix
9.3. Strategic Partnerships, Mergers & Acquisitions
9.4. Key Developments in Product Portfolios and Innovations
9.5. Company Benchmarking

10. Company Profiles

10.1. Merck KGaA*
- 10.1.1. Company Overview
- 10.1.2. Product Portfolio
  - 10.1.2.1. Product Description
  - 10.1.2.2. Product Key Performance Indicators (KPIs)
  - 10.1.2.3. Historic and Forecasted Product Sales
  - 10.1.2.4. Product Sales Volume
- 10.1.3. Financial Overview
  - 10.1.3.1. Company Revenue's
  - 10.1.3.2. Geographical Revenue Shares
  - 10.1.3.3. Revenue Forecasts
- 10.1.4. Key Developments
  - 10.1.4.1. Mergers & Acquisitions
  - 10.1.4.2. Key Product Development Activities
  - 10.1.4.3. Regulatory Approvals, etc.
- 10.1.5. SWOT Analysis
10.2. Yokogawa Electric Corporation
10.3. SATAKE MultiMix Corporation
10.4. B.E.MARUBISHI CO., LTD.
10.5. ABLE Corporation & Biott Corporation
10.6. Eiken Chemical co. Lti.
10.7. BioMerieux S.A.
10.8. Thermo Fisher Scientific, Inc.
10.9. Sartorius AG
10.10. Kerry Group plc.